Cargando…

Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection

Direct-acting antiviral agents (DAAs) for hepatitis C treatment tend to fare better in individuals who are also likely to respond well to interferon-alpha (IFN), a surprising correlation given that DAAs target specific viral proteins whereas IFN triggers a generic antiviral immune response. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venugopal, Vishnu, Padmanabhan, Pranesh, Raja, Rubesh, Dixit, Narendra M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057683/ https://www.ncbi.nlm.nih.gov/pubmed/30001324 http://dx.doi.org/10.1371/journal.pcbi.1006335

Ejemplares similares

Viral Kinetics Suggests a Reconciliation of the Disparate Observations of the Modulation of Claudin-1 Expression on Cells Exposed to Hepatitis C Virus
por: Padmanabhan, Pranesh, et al.
Publicado: (2012)

Mathematical Model of Viral Kinetics In Vitro Estimates the Number of E2-CD81 Complexes Necessary for Hepatitis C Virus Entry
por: Padmanabhan, Pranesh, et al.
Publicado: (2011)

Mutational pathway maps and founder effects define the within-host spectrum of hepatitis C virus mutants resistant to drugs
por: Raja, Rubesh, et al.
Publicado: (2019)

Hepatitis C Virus Infection: Looking for Interferon Free Regimens
por: González-Moreno, J., et al.
Publicado: (2013)

Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
por: Sung, Pil Soo, et al.
Publicado: (2018)

Towards multiscale modeling of the CD8(+) T cell response to viral infections
por: Baral, Subhasish, et al.
Publicado: (2019)

Type III Interferons in Hepatitis C Virus Infection
por: Boisvert, Maude, et al.
Publicado: (2016)

Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection
por: Desikan, Rajat, et al.
Publicado: (2020)

Psoriasis and Hepatitis C: Improvement with Interferon
por: Habte-Gabr, Eyassu, et al.
Publicado: (2011)

Interferon-Free Treatments for Chronic Hepatitis C Genotype 1 Infection
por: FakhriRavari, Alireza, et al.
Publicado: (2016)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Achieving sustained virologic response after interferon‐free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
por: Meissner, E. G., et al.
Publicado: (2016)

Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling
por: Sugiyama, Ryuichi, et al.
Publicado: (2017)

Concise review: Interferon-free treatment of hepatitis C virus-associated cirrhosis and liver graft infection
por: Weiler, Nina, et al.
Publicado: (2016)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy
por: Bruening, Janina, et al.
Publicado: (2017)

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
por: Padmanabhan, Pranesh, et al.
Publicado: (2020)

The New Era of Interferon-Free Treatment of Chronic Hepatitis C
por: Solbach, Philipp, et al.
Publicado: (2015)

STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α
por: Yamauchi, Shota, et al.
Publicado: (2016)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
por: Meissner, Eric G., et al.
Publicado: (2017)

Transcriptional response to hepatitis C virus infection and interferon‐alpha treatment in the human liver
por: Boldanova, Tujana, et al.
Publicado: (2017)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy
por: Jadali, Zohreh
Publicado: (2013)

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
por: Scagnolari, Carolina, et al.
Publicado: (2010)

Interferon-Induced Crohn’s Disease: An Unusual Side Effect of Interferon Therapy in a Patient With Chronic Hepatitis C Virus Infection
por: Basar, Omer, et al.
Publicado: (2021)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes, Jacinta A, et al.
Publicado: (2015)

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
por: Rivero-Juarez, A., et al.
Publicado: (2015)

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients
por: Chayama, Kazuaki, et al.
Publicado: (2015)

Retinopathy associated with interferon therapy in patients with hepatitis C virus
por: Abd El-Badie Mohamed, Mahmoud, et al.
Publicado: (2012)

Interferon-Induced Effector Proteins and Hepatitis C Virus Replication
por: Frese, Michael, et al.
Publicado: (2008)

Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse
por: Tsuge, Masataka, et al.
Publicado: (2011)

Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection
por: Wong, Mun-Teng, et al.
Publicado: (2016)

Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin
por: Wu, Chia-Min, et al.
Publicado: (2021)

Interferon-free treatments in patients with hepatitis C genotype 3 infection in a tertiary hospital
por: del Rio-Valencia, Juan Carlos, et al.
Publicado: (2018)

The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element
por: Guo, Yanan, et al.
Publicado: (2019)

Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era
por: Brzdęk, Michał, et al.
Publicado: (2023)

Interferon Impedes an Early Step of Hepatitis Delta Virus Infection
por: Han, Ziying, et al.
Publicado: (2011)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Type of Pegylated Interferon Matters: Another Milestone in the Treatment of Hepatitis C Virus Infection
por: Singal, Ashwani Kumar
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b4t4d3tetign8uuve6osda2vqj